E-Swasthya Mediserve Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 01-07-2024
- Paid Up Capital ₹ 0.01 Cr
as on 01-07-2024
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Revenue 71.95%
(FY 2021)
- Profit 429.92%
(FY 2021)
- Ebitda 142.30%
(FY 2021)
- Net Worth 30.65%
(FY 2021)
- Total Assets 38.92%
(FY 2021)
About E-Swasthya Mediserve
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 0.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Deepika Shah, Yash Shah, Pina Vyas, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85100GJ2014PTC080406
- Company No.
080406
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Aug 2014
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does E-Swasthya Mediserve Private Limited offer?
E-Swasthya Mediserve Private Limited offers a wide range of products and services, including Physiotherapy & Rehab Aids, Compression Stockings, Ice Packs, Ice Gel Packs, Surgical Instruments, Blood Bank Equipments, Blood Lancet, Personal Weighing Scale, Baby Scales, Surgical & ICU Equipments.
Who are the key members and board of directors at E-Swasthya Mediserve?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vedant Goswami  | Director | 01-Apr-2019 | Current |
| Deepika Shah | Director | 07-Aug-2014 | Current |
| Yash Shah | Director | 07-Aug-2014 | Current |
| Pina Vyas | Additional Director | 14-Jul-2021 | Current |
| Padmajaysinh Rathod | Additional Director | 09-Jan-2020 | Current |
Financial Performance and Corporate Structure Insights of E-Swasthya Mediserve.
E-Swasthya Mediserve Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 71.95% increase. The company also saw a substantial improvement in profitability, with a 429.92% increase in profit. The company's net worth Soared by an impressive increase of 30.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of E-Swasthya Mediserve?
In 2021, E-Swasthya Mediserve had a promoter holding of 74.00% and a public holding of 26.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
2 years 10 months Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at E-Swasthya Mediserve?
Unlock and access historical data on people associated with E-Swasthya Mediserve, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of E-Swasthya Mediserve, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped E-Swasthya Mediserve's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
